Back to Search
ALAN POLLACK, MD
MD
Radiation Oncology Physician
NPI: 1326106105IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
ME102764(FL)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
UNIVERSITY OF MIAMI, LM MILLER SCHOOL OF MEDICINE
Class of 1987
Research & Publications (20)
Early OCT changes of neuroretinal foveal thickness after first versus repeated PDT in AMD.
PMID 18094940·Int Ophthalmol·2009
4-observational
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
PMID 18977097·Int J Radiat Oncol Biol Phys·2009
8-other
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer.
PMID 19464826·Int J Radiat Oncol Biol Phys·2009
8-other
ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
PMID 19386445·Int J Radiat Oncol Biol Phys·2009
6-review
Analysis of targeted mutation in DJ-1 on cellular function in primary astrocytes.
PMID 19063952·Toxicol Lett·2009
7-preclinical
Developing a radiation error scoring system to monitor quality control events in a radiation oncology department.
PMID 19111271·J Am Coll Radiol·2009
8-other
Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use.
PMID 19598213·Laryngoscope·2009
5-case
Predictive models in external beam radiotherapy for clinically localized prostate cancer.
PMID 19544539·Cancer·2009
6-review
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.
PMID 19470936·J Clin Oncol·2009
2-rct
Long-term follow up of antenatally diagnosed megaureters.
PMID 18631923·J Pediatr Urol·2008
4-observational
Longitudinal associations among quality of life and its predictors in patients treated for prostate cancer: the moderating role of age.
PMID 18350459·Psychol Health Med·2008
8-other
Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration.
PMID 19085384·Curr Eye Res·2008
2-rct
Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel.
PMID 19065273·Mol Vis·2008
8-other
Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation.
PMID 19010821·Mol Cancer Res·2008
8-other
Does treatment duration affect outcome after radiotherapy for prostate cancer?
PMID 18472368·Int J Radiat Oncol Biol Phys·2008
8-other
Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.
PMID 18455330·Int J Radiat Oncol Biol Phys·2008
3-trial
Behavioral disorders in children with idiopathic intracranial hypertension.
PMID 18401035·J Child Neurol·2008
3-trial
Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mg.
PMID 18536598·Retina·2008
4-observational
Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel.
PMID 18852870·Mol Vis·2008
8-other
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
PMID 18672274·Urology·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1475 NW 12TH AVE, SUITE 1500
MIAMI, FL 33136 - Phone
- (305) 243-4916
Quick Facts
- NPI
- 1326106105
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile